BioPlus Acquisition Corp.BIOSNASDAQ
Loading
BIOS Revenue Growth (YoY Quarterly)•+0.00%
Stock Alarm Pro
Growth Metrics
Latest: Q2 2023vs Q1 2023
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+4879.74%
+4879.7pp
+1062.79%
+1062.8pp
+5455.56%
+5455.6pp
+325.77%
+345.4pp
-16.47%
+3.1pp
+0.00%
+0.0pp
| Metric | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | -3352408.67% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +4879.74% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +1062.79% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +5455.56% |
| Weighted Average Shares Growth | -0.12% | +326.28% | +4781088.51% | -19.62% | +325.77% |
| Weighted Average Shares Diluted Growth | +409.74% | +326.28% | +211329.26% | -19.62% | -16.47% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +0.00% | +46645.01% | +0.99% | +2.14% | -41.21% |
| Book Value per Share Growth | +0.00% | +288747.19% | -100.00% | +26.99% | -87.04% |
| Debt Growth | +0.00% | +3746.15% | +0.00% | +0.00% | +5.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +22305.61% | +33009.24% | -548956.60% | -99.91% | +400.74% |
1 / 4